Occurrence of Fibrotic Tumor Vessels in Grade I Meningiomas Is Strongly Associated with Vessel Density, Expression of VEGF, PlGF, IGFBP-3 and Tumor Recurrence.

IGFBP-3 PlGF VEGF angiogenesis antiangiogenic therapy grade I meningioma magnetic resonance imaging recurrence

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
21 Oct 2020
Historique:
received: 02 10 2020
accepted: 16 10 2020
entrez: 24 10 2020
pubmed: 25 10 2020
medline: 25 10 2020
Statut: epublish

Résumé

Angiogenesis is a key feature during oncogenesis and remains a potential target of antiangiogenic therapy. While commonly described in high-grade lesions, vascularization and its correlation with prognosis in grade I meningiomas is largely unexplored. In the histological classification, not only the number but also the composition of blood vessels seems to be important. Therefore, tumor vessel density and fibrosis were correlated with clinical and imaging variables and prognosis in 295 patients with intracranial grade I meningioma. Expression of pro-angiogenic proteins within the meningiomas was investigated by proteome analyses and further validated by immunohistochemical staining. Fibrotic tumor vessels (FTV) were detected in 48% of all tumors and strongly correlated with vessel density, but not with the histopathological tumor subtype. Occurrence of FTV was correlated with a 2-fold increased risk of recurrence in both univariate and multivariate analyses. Explorative proteome analyses revealed upregulation of VEGF (vascular endothelial growth factor), PlGF (placental growth factor), and IGFBP-3 (insulin-like growth factor-binding protein-3) in tumors displaying FTV. Immunohistochemical analyses confirmed strong correlations between tumor vessel fibrosis and expression of VEGF, PlGF, and IGFBP-3. Presence of FTV was strongly associated with disruption of the arachnoid layer on preoperative MRI in univariate and multivariate analyses. In summary, the occurrence of fibrotic tumor vessels in grade I meningiomas is strongly associated with vessel density, disruption of the arachnoid layer, expression of VEGF, PlGF, IGFBP-3 and tumor recurrence.

Identifiants

pubmed: 33096816
pii: cancers12103075
doi: 10.3390/cancers12103075
pmc: PMC7593950
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Lancet Oncol. 2016 Sep;17(9):e383-91
pubmed: 27599143
Sci Rep. 2020 Jul 8;10(1):11220
pubmed: 32641701
J Neurol Neurosurg Psychiatry. 1957 Feb;20(1):22-39
pubmed: 13406590
Rheum Dis Clin North Am. 1996 Nov;22(4):751-64
pubmed: 8923594
J Neurooncol. 2012 Aug;109(1):63-70
pubmed: 22535433
World Neurosurg. 2019 Aug;128:174-181
pubmed: 31082555
Neuro Oncol. 2015 Jan;17(1):116-21
pubmed: 25100872
J Neurooncol. 2017 Jul;133(3):641-651
pubmed: 28527009
J Craniomaxillofac Surg. 2016 Dec;44(12):1896-1902
pubmed: 27863864
Biomed Res Int. 2015;2015:646853
pubmed: 25821815
J Ophthalmol. 2011;2011:584238
pubmed: 21584260
Neurosurg Focus. 2007;23(4):E12
pubmed: 17961036
J Neurosurg. 2018 Apr 27;130(3):789-796
pubmed: 29701550
Angiogenesis. 2017 Nov;20(4):409-426
pubmed: 28660302
Ann Med. 2009;41(4):257-64
pubmed: 19089693
Blood. 2011 Sep 1;118(9):2622-31
pubmed: 21551235
Int J Cancer. 2005 Mar 20;114(2):249-56
pubmed: 15540215
Acta Neuropathol. 2019 Aug;138(2):295-308
pubmed: 31069492
Br J Dermatol. 1998 Dec;139(6):1049-51
pubmed: 9990370
Neurol Res. 2005 Jun;27(4):371-7
pubmed: 15949234
Oncologist. 2011;16(11):1604-13
pubmed: 22028341
Growth Horm IGF Res. 2014 Oct;24(5):164-73
pubmed: 24953254
Acta Neuropathol. 1998 Nov;96(5):453-62
pubmed: 9829808
J Neurosurg. 2018 Mar;128(3):657-666
pubmed: 28362240
Exp Mol Med. 2012 Jan 31;44(1):1-9
pubmed: 22228176
Acta Neurochir (Wien). 2018 Sep;160(9):1801-1812
pubmed: 29974236
Curr Drug Targets. 2010 Aug;11(8):1000-17
pubmed: 20426765
J Neurooncol. 2014 Mar;117(1):93-101
pubmed: 24449400
Neurosurg Focus. 2013 Dec;35(6):E18
pubmed: 24289126
Eur J Cancer. 2005 Dec;41(18):2819-27
pubmed: 16275058
Neurosurg Focus. 2018 Jun;44(6):E10
pubmed: 29852774
Acta Neurochir (Wien). 2019 Aug;161(8):1647-1656
pubmed: 31147831
Diabetes Res Clin Pract. 2020 Apr;162:108083
pubmed: 32057965
Neuroradiol J. 2017 Feb;30(1):48-56
pubmed: 28059671
Trends Immunol. 2005 Nov;26(11):587-95
pubmed: 16168711
Neuropathol Appl Neurobiol. 2004 Apr;30(2):118-25
pubmed: 15043709
Neuropathology. 2010 Oct;30(5):537-46
pubmed: 20337947
Am J Surg Pathol. 2004 Mar;28(3):390-3
pubmed: 15104303
Mol Cancer Res. 2017 Jul;15(7):896-904
pubmed: 28330997
J Neuropathol Exp Neurol. 2016 Dec 1;75(12):1160-1170
pubmed: 27807004
Cancers (Basel). 2019 Apr 15;11(4):
pubmed: 30991738
Neurosurgery. 1994 Sep;35(3):439-48; discussion 448-9
pubmed: 7528359
Endocr Rev. 1997 Feb;18(1):4-25
pubmed: 9034784
J Neurosurg. 2017 Apr;126(4):1201-1211
pubmed: 27257838
Clin Neurol Neurosurg. 2016 Oct;149:111-7
pubmed: 27513979
Cardiovasc Res. 2013 Sep 1;99(4):716-23
pubmed: 23756254
APMIS. 2014 Jan;122(1):16-24
pubmed: 23756256
Lancet Oncol. 2017 May;18(5):682-694
pubmed: 28314689
Am J Physiol Cell Physiol. 2009 May;296(5):C954-76
pubmed: 19279229
J Pathol. 1999 Sep;189(1):66-71
pubmed: 10451490
Gut. 2005 May;54(5):666-72
pubmed: 15831913
World Neurosurg. 2016 Sep;93:346-54
pubmed: 27344043
World Neurosurg. 2017 Dec;108:465-473
pubmed: 28844928
Neuro Oncol. 2012 May;14(5):658-66
pubmed: 22406926
Oncol Lett. 2017 May;13(5):3958-3966
pubmed: 28521493
Acta Neuropathol. 2013 Nov;126(5):757-62
pubmed: 24096618
Neurosurgery. 2020 Mar 1;86(3):E362-E365
pubmed: 31792502
Chest. 2002 Dec;122(6 Suppl):298S-301S
pubmed: 12475804
Neurosurgery. 2000 Apr;46(4):938-47; discussion 947-8
pubmed: 10764269
Oncotarget. 2018 Nov 13;9(89):35974-35982
pubmed: 30542511
J Oncol Pharm Pract. 2019 Apr;25(3):638-647
pubmed: 30253729
Cancer. 1997 May 15;79(10):2003-15
pubmed: 9149029
Acta Neuropathol. 2013 Mar;125(3):351-8
pubmed: 23404370
Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):492-497
pubmed: 28034921

Auteurs

Katharina Hess (K)

Vascular Research Center, University Hospital of Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany.
Department of Pathology, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, 24105 Kiel, Germany.

Dorothee Cäcilia Spille (DC)

Department of Neurosurgery, University Hospital Münster, 48149 Münster, Germany.

Alborz Adeli (A)

Institute of Clinical Radiology, University Hospital Münster, 48149 Münster, Germany.

Peter B Sporns (PB)

Institute of Clinical Radiology, University Hospital Münster, 48149 Münster, Germany.

Karina Zitta (K)

Department of Anesthesiology and Intensive Care Medicine, University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany.

Lars Hummitzsch (L)

Department of Anesthesiology and Intensive Care Medicine, University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany.

Julian Pfarr (J)

Department of Radiology and Neuroradiology, University Hospital of Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany.

Walter Stummer (W)

Department of Neurosurgery, University Hospital Münster, 48149 Münster, Germany.

Benjamin Brokinkel (B)

Department of Neurosurgery, University Hospital Münster, 48149 Münster, Germany.

Rouven Berndt (R)

Department of Cardiovascular Surgery, Vascular Research Center, University Hospital of Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany.

Martin Albrecht (M)

Department of Anesthesiology and Intensive Care Medicine, University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany.

Classifications MeSH